MOLN
Molecular Partners AG American Depositary SharesRecent alerts on MOLN
All signals →
SEC filing
MOLN Presents MP0712 Phase 1/2a Trial Updates at ASCO and SNMMI 2026, Dosing Patients with DLL3-Targeting Radio-DARPin Therapy
1d ago
SEC filing
MOLN Reports $12B Revenue, $3.4B Net Income, Announces $20B Buyback
32d ago
SEC filing
MOLN Elects Clare Fisher to Board, Approves $57.9M 2025 Loss Carryforward, Grants Discharge
48d ago
SEC filing
MOLN Reports $93.1M Cash Runway to 2028, Initiates US Phase 1/2a DLL3 Radio-DARPin MP0712 Trial, Advances MSLN Candidate MP0726, Signs Eckert & Ziegler Radio-Isotope Deal
81d ago
SEC filing
MOLN Reports $0 Revenue, $0 EPS, CHF 93.1M Cash, CHF 51.3M Operating Outflow, CHF 45-55M 2026 Expense Outlook
81d ago
News
Molecular Partners GAAP EPS of -CHF1.65 beats by CHF0.32
81d ago
News
L’Oreal Earnings: Solid Results Showcase Brand Strength and Operational Agility - Morningstar Canada
105d ago
News
Self-driving truck startup Waabi is teaming up with Uber on robotaxis
125d ago
Scanner
Unusual volume (14.5x average)
125d ago
News
Molecular Partners Reports Q3 2025 Financial Results and Clinical Progress, with DLL3-Targeting Radio-DARPin MP0712 Phase 1 Launch Expected in 2025
153d ago
News
Molecular Partners to Present at 44th Annual J.P. Morgan Healthcare Conference
165d ago
News
Molecular Partners to Present at 44th Annual J.P. Morgan Healthcare Conference
166d ago
Get push alerts for MOLN
Add it to your watchlist in the app and receive every signal the moment it fires.
Download for iOS